Drug manufacturers in New York may soon be required to fund and operate take-back programs to dispose of unused drugs, as the state’s legislature voted unanimously last week to send legislation to the governor’s desk.
The Drug Take Back Act (S. 9100) requires manufacturers — or drug take-back organizations hired by them — to submit a proposed take back-program within 180 days of the act becoming law. Manufacturers may also enter into an agreement with the Department of Health to operate a drug take-back program on the company’s behalf. The program must meet certain requirements, such as certifying that it will accept all covered drugs regardless of the manufacturer.
The programs must provide a convenient method of collecting drugs for disposal and be accessible to people in rural and underserved areas. The drugs must be handled and tracked throughout the entire process, from collection until their destruction, which must comply with federal requirements. Chain and mail-order pharmacies will need to provide on-site collection, dropboxes or mail-back collection via prepaid envelopes.